Event Program

Advancing Supply Chain Management
in the Biopharma Industry
BIO SUPPLY MANAGEMENT ALLIANCE
Because life depends on us™
gold sponsor
track sponsors
silver sponsor
bronze sponsors
participating sponsors
association sponsors
San Francisco Roundtable
Council of Supply Chain
Management Professionals
ISM—Northern California, Inc.
OCTOBER 23-24, 2014 CROWNE PLAZA FOSTER CITY, CALIFORNIA
www.biosupplyalliance.coM
BIO SUPPLY MANAGEMENT ALLIANCE
MissionStatement
ExecutiveCommittee
To build effective and efficient supply chain STRATEGY for the
biotech, biopharma, pharma and biomedical device industries
by developing, advancing, and disseminating best practices,
knowledge, and research.
To encourage and promote supply chain INNOVATION within
the biotech, biopharma, pharma and biomedical device
industries for the highest quality and clinical outcomes in
patient care and welfare.
To create a supply chain COMMUNITY of thought and practice
leaders from the business, professional association and
academic sectors for information exchange, shared services,
and collaboration.
Devendra Mishra
EXECUTIVE DIRECTOR & CO-FOUNDER
Dave Malefant
EXECUTIVE VICE PRESIDENT, INDUSTRY LIAISON &
TALENT DEVELOPMENT
Shankar Suryanarayanan
VICE PRESIDENT, STRATEGIC PLANNING &
INTERNATIONAL
Bill Coakley
VICE PRESIDENT, STRATEGIC ALLIANCE
Vishal Singal
VICE PRESIDENT, COLD CHAIN & EMERGING
MARKETS
Deborah Rice
VICE PRESIDENT, SPONSOR SALES & MEMBERSHIP
Dotti Yells
VICE PRESIDENT, MARKETING , WEBMASTER & DBA
Wayne McDonell
INDUSTRY LEADER, PwC
John Mitch
LEGAL COUNSEL
AdvisoryBoard
Anderson
Aphale
Buck
Dawe
Kachinsky
Kaminsky
Malenfant
Paul Anderson, Vice President of Global Procurement,
Life technologies
Jayant Aphale, Senior Vice President, Technical
Operations, Serepta Therapeutics
Mark Buck, Global supply chain and Procurement
Leader, bio-rad Laboratories
Dr. Richard L. Dawe, Director of the Operations &
supply chain Management Program and the center of
Operations Management, Golden Gate University
Mary Kachinsky, sr. Director of strategic sourcing, cubist
Pharmaceuticals
Phil Kaminsky, Associate Professor, school of industrial
engineering & Operations research, University of
california, berkeley
Dave Malefant, Executive Vice President, Industry
Liaison and Talent Development, BSMA
Nancy Nix, Ph.D, Director, executive MbA Program,
Professor, texas christian University board chair, elect
council supply chain Management Professionals
paGe
2
Nix
Pegels
seaback
singh
Somerville
Suryanarayanan
Tenerowicz
Waller
Kevin Pegels, Vice President, Global supply chain UsA,
bayer Healthcare - Ps biotech
Paul Seaback, Head of Global supply chain, Gilead
sciences
Mahender Singh, Ph.D., research Director, center for
transportation and Logistics, Massachusetts institute of
technology
Susanne Somerville, Vice President, supply chain
North America region, Genentech (A roche company)
Shankar Suryanarayanan, Director, Manufacturing
strategy, baxter international
Rob Tenerowicz, Vice President, supply chain
Management, bioMarin
Rayne Waller, Vice President, Global supply chain,
Amgen
/ bio supply ManaGeMent alliance 2014
www.biosupplyalliance.com
October 23, 2014
BIO SUPPLY MANAGEMENT ALLIANCE
CONFERENCE PROGRAM
9:00 –11:00am PLANT TOURS
Bio-Rad Instrument Assembly & Distribution Center, Hercules
Genentech, South San Francisco
2:30-3:00pm "Contract Manufacturing: Establishing a Core
Competency" ~ continued
he impediments to be overcome and how transparency and
collaboration is achieved with people, processes and technologies.
Paul Seaback, Vice President, Global Supply Chain, Gilead Sciences
12:00pm REGISTRATION
1:00-5:30pm PLENARY SESSION
3:00-3:30pm “Building Information Systems to Support
Strategic Sourcing from Scratch"
1:00-1;15pm WELCOME ADDRESS: "ManufacturerSupplier Collaboration: New Rules of Engagement"
Technology in a Flat World is enabling collaboration for productivity in
ways that are unprecedented. Best practices from other industries will
be presented for consideration in the biopharma industry. New rules of
engage ment will be described to meet the emerging challenges of
ensuring global supply chain integrity while achieving system-wide cost
minimization.
Devendra Mishra, Executive Director, BSMA
C
A case study of how the challenges faced when the executive first joined
Cubist with no systems and tools to understand our spend and to be
able to identify opportunities for strategic sourcing, cost reduction,
supplier optimization and/or supplier management, etc. A customer
driven, low cost solution was successfully implemented with
extraordinary results. Mary Kachinsky, Senior Director, Strategic Sourcing, Cubist
Pharmaceuticals
3:30-4:00pm NETWORK BREAK
4:00-4:30pm “Emerging Trends with Medical Devices in
Biotech”
There is an emerging trend of drug delivery/medical devices being
integrated with the packaging of biotechnology products. When
manufacturers add drug delivery devices as part of their primary
packaging, it is classified as a combination product. The presentation
will highlight some of the reasons why and benefits to the patient
community. The latest regulatory and compliance requirements for
combination products will also be outlined.
Kevin Prosise, Operations Manager, Bayer Healthcare
4:30-5:00pm “The Drug Supply Chain Security Act: At the
Cross Hair"
2:00-2:30pm “Are you Ready for Supply Chain Segmentation
for Greater Profits and Service?”
Early lessons learned from this strategy of supply chain segmentation
will be highlighted to find the best supply chain processes and policies
to serve each customer and each product at a given point in time while
also maximizing both customer service and company profitability. A
framework will be discussed to drive such a process while giving
consideration to company’s capabilities and the challenges throughout
the entire lifecycle.
Rayne Waller, Vice President, Global Supply Chain, Amgen
2:30-3:00pm "Contract Manufacturing: Establishing a Core
Competency"
Realizing the strategic value of contract manufacturing in a
marketplace of uncertainty and volatility of demand, risk of
performance to schedule, capital investment constraints and product
quality considerations is a long and difficult journey that Gilead
Sciences has undertaken successfully. As a result, Virtual Supply Chain
Management has become a core competency. Presentation will include
m
Last November, President Obama signed the Drug Quality and Security
Act. Title II, the Drug Supply Chain Security Act (DSCSA), requires
the Secretary to establish federal guidelines for licensing wholesalers
and third-party logistics providers (3PLs) and the development of an
interoperable “Track and Trace” system that pre-empts existing state
pedigree laws. Presentation will provide an informative update and
timeline assessment for these new requirements, focusing on the initial
efforts with FDA, supply chain stakeholders, and Congress to achieve
the interoperable “Track and Trace” system as well as touch on an
International perspective and global challenges.
Chip Meyers, Vice-President, Corporate Public Affairs, UPS
5:00-5:15pm SCM INNOVATION AWARDS
5:15-6:30pm COCKTAIL RECEPTION
bio supply ManaGeMent alliance 2014 / PAGE
3
October 24, 2014
BIO SUPPLY MANAGEMENT ALLIANCE
CONFERENCE PROGRAM
8:30am-4:45pm TRACK 1: STRATEGIC SOURCING - Track Coordinator: Jim Latimer, Sourcing Leader, Lawrence Berkeley
National Laboratories
8:30-9:15am PANEL: "Leveraging Strategic Sourcing for
Startups, Small and Mid-Sized Companies in Biotech,
Pharma and Medical Devices"
Sourcing for R&D, Clinical Trials and Commercialization is a
formidable challenge for small and large companies. The global market
place, inter-dependence of trading partners in the supply chain,
emerging markets of suppliers, IT connectivity and stringent
requirements of agility, cost reduction, quality, sustainability of the
environment and safety have added challenges to management
responsible for strategic sourcing.
Panelists:
Isaac Young, Sr. Director Supply Chain Operations, BioMarin
Pharmaceuticals
Mary Kachinsky, Sr. Director, Strategic Sourcing, Cubist
Pharmaceuticals
Sophia Sharp-Donaldson, Head of Strategic Sourcing & Global
Logistics, Baxter Healthcare
Mark Buck, Global Supply Chain and Procurement Leader, Bio-Rad
Moderator: Jim Latimer, Sourcing Leader, Lawrence Berkeley
National Laboratories
9:15-9:45am "Rx-360 Upstream Supply Chain Security: A
Supplier Collaborative Approach to Mitigate Risk and
Enhance Transparency" Presentation on best demonstrated practices (BDPs) in the areas of
Supply Chain Security Awareness, Supply Chain Mapping, Risk
Assessment Tools and Risk Assessment Approaches, the Importance of
Intended Use of the Product, Supplier Questionnaires / Surveys and
Change Control and Change Notification. The content was developed
after assessing the Rx-360 membership survey on upstream supply
chain security business practices of over 80% of the top 15 largest
global pharmaceutical manufacturers. The presentation will focus on
BDPs to improve quality through supplier and industry collaboration.
Rob Welsh, VP, Category Management, Production Chemical
Operations, VWR International
9:45-10:15am NETWORK BREAK
10:15-10:45am "A New Perspective on Mentoring: Peer
Mentoring at Cubist Pharmaceuticals"
The traditional mentoring relationship, pairing a junior employee with
one senior colleague, is not enough in today’s rapidly changing,
increasingly complex work environments. No one mentor can be
expected to provide all the necessary knowledge, guidance, and
opportunities for career advancement and professional
development. Based on the thought leadership of Kathy E. Kram,
Professor of Organizational Behavior at Boston University’s School of
Management, and Monica C. Higgins, Professor of Education at Harvard University’s Graduate School of Education, Cubist
Pharmaceuticals has embraced a new approach to mentoring—Peer
Mentoring. Claire Joyce, Senior Manager of Learning and
Development, will discuss the genesis and implementation of Cubist’s
two peer mentoring programs, together with the response from
employees.
Claire Joyce, Senior Manager, Learning and Development, Cubist
Pharmaceuticals paGe
4
10:45-11:45am "Town Hall Meeting for Interactive Solution
Development"
The attendees will be assigned to groups for Supplier Relations
Management, Systems, HR Development of Executives, Risk
Management and other burning issues so that issues and answers can be
addressed. The individual teams will present their findings and
initiatives to the general assembly.
Leaders:
Jim Latimer, Sourcing Leader, Lawrence Berkeley National
Laboratories
Mary Kachinsky, Sr. Director, Strategic Sourcing, Cubist
Pharmaceuticals
Claire Scarborough Joyce, Manager, Learning & Development, Cubist
Pharmaceuticals
Christelle Laot, Technical fellow, Life Sciences & Specialty Services.
FedEx
11:45-12:30pm "Report from the Town Hall Meeting"
Spokespersons:
Supplier Relations Management: Jim Latimer
Systems and Technology: Mary Kachinsky
HR Development: Claire Scarborough Joyce
Risk Management: Christelle Laot
12:30-1:30pm NETWORK LUNCH
1:30-2:30pm “The DNA of Source-to-Pay: Cracking the Code
on a Business Case for Procurement Transformation”
Driving transformational change across Source-to-Pay processes
requires a formula that consists of these key elements: 1)
Rock solid business case analytics, 2) Transformational technology and
robust implementation planning, and 3) a Vision of the “To Be” end
state process. This session will highlight best practice strategies, relevant
benchmarks, and a methodology for developing the right formula for a
winning business case and successful execution of transformational
change. The key takeaways include Sample Business Case Analytics for
S2P ROI Justification, Benchmarks for Monitoring and Measuring
Performance and Vision of Future State – Procurement Transformed.
Richard Waugh, Vice-President, Corporate Development, ZYCUS
2:30-3:00pm “Developing Transformative Biotech Strategies –
The Technology Way!”
Truly transformative change is hard, but innovative companies are
doing it today at an ever-increasing pace. Explore some of the
information, technologies, personnel and paradigm shifts that are
allowing bio-companies to re-model their cost-side strategies in ways
which optimize their potential for growth and innovation.
John Lark, Senior Director, Solutions Marketing, Ariba
/ bio supply ManaGeMent alliance 2014
3:00-3:30pm NETWORK BREAK
www.biosupplyalliance.com
8:30am-4:45pm TRACK 1: STRATEGIC SOURCING - Track Coordinator: Jim Latimer, Sourcing Leader, Lawrence Berkeley
National Laboratories
3:30-4:00pm “Accelerating Beyond Post Market Surveillance”
Post Market Surveillance is the practice of monitoring the safety of a
pharmaceutical drug or medical device after it has been released on the
market and is an important part of the science of pharmacovigilane. In
today’s fast moving Medical device industry it is important to develop
highly effective monitoring and cross functional decision making
process to adapt quickly to the changing customer uses. Focus will be
on establishing an effective cross functional collaboration across Sales,
Field Service, Marketing, Product Management, Technical Service, and
Operations to fully identify the changing voice of the customer and
establish effective mechanisms to pro-actively evolve products and
specifications. Several tools will be introduce to help this identification.
Johan Denecke, Sr. Director, Global Quality Assurance, Life Sciences Solutions,
Thermofisher
8:30am-4:45pm TRACK 2: CLINICAL SERVICES SUPPLY CHAIN & COLD CHAIN - Track Coordinator: Vishal Singal, Vice
President, Cold Chain & Emerging Markets, BSMA
10:15-10:45am “New Technology Assisting & Empowering
the Global Supply Chain”
8:30-9:15am "Clinical Operations Management: Best
Practices and Services for the Global Marketplace”
Presentation of how supply chain can support clinical development and
help serve as a launching point for commercial success in the most
economical and timely manner. Learn and share with your peers
solutions and best practices to common challenges encountered in
clinical supply chain. Hear how the experts perform forecasting,
determine safety stock levels, manage inventory, reduce costs and lead
times, satisfy labeling, packaging and cold chain requirements, and
handle shipments to emerging markets. The IT Integration in the
supply chain will be discussed.
Panelists:
Bill Coakley, Director, Supply Chain Planning, Bio-Marin
Luke Moyer, Project Services Liaison, Almac Clinical Services
Irene Ping Xie, Sr. Manager, Clinical Supply Management, Gilead
Sciences
Michael Moro, PMP, Senior Manager Clinical Trial Materials, Acadia
Pharmaceuticals
Moderator: Devendra Mishra, Executive Director, BSMA
9:15-9:45am “Global Clinical Supplies & The Road Less
Traveled: Navigating the bumps, pot holes and detours that
come with the development and delivery of Investigational
Products.”
Commercial supply chains are characterized by efficiency, throughput,
automation and real time tracking of goods. They are equivalent of a
well paved, fast motorway. While clinical supply chains can learn a
great deal from their commercial counterparts, they also must operate
in an environment that is predictably ever changing, has added
regulatory and distribution constraints, is subject to scientific
"surprises", and on the critical path to new product launches. Perhaps
the equivalent of an unpaved shortcut through the briar patch... Learn
more about the differences in commercial and clinical supplies,
regulatory drivers, operational challenges as well as strategies for
delivering on time, every time. Lorna Briddick, Managing Partner, Brizzey LLC
9:45-10:15am NETWORK BREAK
www.biosupplyalliance.com
New products types and movement of materials across temperature and
time zones has spurred innovation across the clinical supply chain.
Hear about some of the more interesting technology that has emerged
and why it is making a difference to clinical supply chain professionals
and investigator sites around the world. What are unmet needs that
still exist today and are there any relevant possibilities from the
commercial world that might be able to help clinical teams still facing
challenges.
Alex Guillen, Director, Global Cold Chain, Fisher Clinical Services
Michael Moro, PMP, Senior Manager Clinical Trial Materials, Acadia
Pharmaceuticals
10:45-11:15am "Risk Management Methods Applied to
Healthcare Transportation Solutions"
Transportation providers are leveraging risk management methods
used by the pharmaceutical and biotech industry to build a
comprehensive risk-based approach towards shipping solutions, and in
particular towards those dedicated to temperature-sensitive shipments.
A few FedEx Express examples will be used to illustrate how robust risk
management documents and protocols can be created for specific
transportation products and services. Risk assessment, risk
quantification, and risk control will be addressed. Findings of the risk
management exercise enable logistics departments to take advantage of
analytical methods to prioritize activities, resources, and investments.
Christelle Laot, Technical Fellow - Cold Chain Management, Life
Sciences & Specialty Services, FedEx
Irene Ping Xie, Sr. Manager, Clinical Supply Management, Gilead
11:45-12:30pm "Town Hall Meeting for Interactive Solution
Development"
The attendees will be assigned to groups for Supplier Relations
Management, Information Systems and Technology, Regulatory
Matters in Emerging Markets, Risk Management and other burning
issues so that issues and answers can be addressed.
Leaders:
Bill Coakley, Director, Supply Chain Planning, Bio-Marin
Vishal Singal, Vice President, Cold Chain & Emerging Markets, BSMA
bio supply ManaGeMent alliance 2014 / paGe
5
8:30am-4:45pm TRACK 2: CLINICAL SERVICES SUPPLY CHAIN & COLD CHAIN - Track Coordinator: Vishal Singal, Vice President,
Cold Chain & Emerging Markets, BSMA
12:30-1:30pm NETWORK LUNCH
1:30-2:15pm "Report from the Town Hall Meeting" Leaders
of the individual teams will present their findings and initiatives
to the general assembly.
Spokespersons:
CC Technology
CC Best Practices
CC Regulation
CO Planning
CO Best Practices
CO Regulation
2:15-3:00pm PANEL: “Temperature-Controlled and Cold
Chain Supply Chain: Proven Technologies and Practices for
Compliance”
Deployment of the emerging temperature-controlled logistics and cold
chain technology, manifesting from end-to-end of the supply chain,
requires packaging engineering standards, business processes,
information systems and monitoring mechanisms. The stakeholders
will discuss the pitfalls and present a blueprint for the manufacturing,
logistics and distribution of temperature-sensitive materials and
finished products globally.
Panelists:
Jim Peyton, Associate Director, Supply Chain, Gilead Sciences
Wahiba Hall, Senior Manager Global Logistics/Cold Chain
Management, Bayer HealthCare
Karl Schlenker, VP Business Development, va-Q-tec USA
Doug Wettegren, Regional Sales Manager & Global Key Account
Manager, Envirotainer
Moderator: Vishal Singal, Vice President, Cold Chain & Emerging
Markets, BSMA
paGe
6
3:00-3:30pm “Track and Trace Solutions Available in the
Industry: A Research Perspective”
How can track and trace technology be employed to improve supply
chain security? This session review the development of track-and-trace
services that are being offered by transport service providers and
discuss what is new to the market. A demonstration of the technology
will also be given.
Chris Fore, Compliance Manager, Envirotainer
3:30-4:00pm NETWORK BREAK
4:00-4:30pm “Qualification & Validation Best Practices”
Due diligence in cold chain means not simply using a qualified shipper,
but qualifying the shipper to perform within the condition of the entire
shipping process, whether overnight to the Midwest, or four days to the
Far East. Commissioning a transit study to qualify your shipping
system will lower costs in a number of ways. This includes dramatically
reducing loss of material and the repetitive testing of suspect material.
A transit study will allow you to identify when a more expensive
shipper combined with a less expensive transport option, such as twoday ground vs. overnight, is more cost effective than a less expensive
shipper, combined with occasional use of a specialized courier service. Jim Peyton, Associate Director, Supply Chain, Gilead Sciences
/ bio supply ManaGeMent alliance 2014
4:30pm WRAP UP
www.biosupplyalliance.com
BIO SUPPLY MANAGEMENT ALLIANCE
2014
speakers, presenters, & panelists
thank you to our
Aphale
Briddick
Buck
Coakley
Denecke
Fore
Jordan
Joyce
Kachinsky
Laot
Lark
Latimer
Marcus
Meyers
Parkhurst
Pegels
Peyton
Prosise
Seaback
Somerville
Toussaint
Moro
Guillen
Hingst
Mishra
SharpDonaldson
Waller
Waugh
Welsh
Wettergren
Moyer
Singal
Xie
Young
academic sponsors
Because life depends on us™
m
bio supply ManaGeMent alliance 2014 / PAGE
7
BIO SUPPLY MANAGEMENT ALLIANCE
Because life depends on us™
Bio Supply Management Alliance membership is open to
those who belong or have an interest in the operations and
supply chain activities in the bio life sciences. The member
dues cover all subsidiaries of the entity. BSMA is dedicated to
increasing the capabilities and knowledge of bio life sciences
supply chain management professionals worldwide.
MEMBERSHIP APPLICATION
______________________________________________________ _____________________________________
COMPANY NAME
WEBSITE
HEADQUARTERS ADDRESS
LATEST Y/E REVENUES
TICKER SYMBOL
CITY
STATE/PROVINCE
COUNTRY
______________________________________________________ __________________ __________________
______________________________________________________ __________________ ________ _________
POSTAL CODE
PRIMARY CONTACT
______________________________________________________ __________________ __________________
NAME
WORK PHONE
TITLE
MOBILE PHONE
ADDRESS
EMAIL
CITY
STATE/PROVINCE
FAX
______________________________________________________ _____________________________________
______________________________________________________ _____________________________________
______________________________________________________ __________________ ________ _________
COUNTRY
POSTAL CODE
MEMBERSHIP CATEGORY (CHECK ONE)
Member Category
Member Description
Annual Dues
Executive Membership Level 1
Annual Revenues Greater than $1 Billion
$12,500____
Executive Membership Level 2
Annual Revenues Less Than or Equal to $1 Billion
$6,500____
Executive Membership Level 3
Emerging and Startup Drug Companies
without a commercial product
$2,000____
Affiliate Membership 1
Annual Revenues Greater than $250 million
$6,500____
Affiliate Membership 2
Annual Revenues Less than or Equal to $250 million
$2,500____
Academia Membership
Any accredited academic institution that works in
support of the bio life sciences.
$500____
Individual Membership
Annual Revenues Greater than $1 Billion
$500____
(select one)
PAYMENT
Membership is effective upon receipt of dues payment and is active for twelve (12) months thereafter. If paying by check, make payable to BIO
SUPPLY MANAGEMENT ALLIANCE. Send completed application to Devendra Mishra, 23681 Park Andorra, Calabasas, CA 91302 or fax to 513893-2107
_____________________________________________________________________________________________
CREDIT CARD NUMBER or CHECK NUMBER
EXPIRATION DATE
CDC
_____________________________________________________________________________________________
NAME ON CREDIT CARD
SIGNATURE
DATE
JOIN THE
BIO SUPPLY MANAGEMENT ALLIANCE
Supply Chain Leadership & Excellence
Become a member of the world’s leading organization for operations and supply chain
management professionals in the bio life sciences industry. Because life depends on us™,
the Bio Supply Management Alliance supports continuous learning and development of bio
supply management professionals and the enhancement and efficacy of the supply chain in
the industry through collaboration.
MembershipBenefits
• Advisory board membership
• Participation in industry-specific steering committees
• Passes to BSMA partner events
• Marketing and advertising in quarterly industry journal
• Upgrade on sponsorship and group registration packages to partner
events
• Exclusive banner ad on newsletter and top rotation on Alliance website
• Company logo on organization communications
• Exclusive access to Alliance online community
• Discounts to Alliance events
• Exclusive access to online presentations from BSMA sponsored events
FIND OUT MORE:
www.biosupplyalliance.com
Because life depends on us™
JOIN THE
BIO SUPPLY MANAGEMENT ALLIANCE
STEERING
COMMITTEES
PROMOTING INDUSTRY SUPPLY CHAIN INITIATIVES!
SUPPLY CHAIN INFORMATION MANAGEMENT
(SCIM) STEERING COMMITTEE
Identifying the best information and systems technology required to meet
the complex technology needs of the biotech and pharma supply chain.
CHAIRPERSON: Grant Hodgkins, Strategy Standards & Process
Manager, Global Supply Chain, Alcon Laboratories
Committee Members:
• R. Arun Kumar, VP, Global Sales, Capgemini
• Colin Finn, Founder and VP, Marketing, Pelyco Systems
• Kevin Riccoboni, IT Leader, Global Operations, Life
Technologies
• Lou Killian, Enterprise Systems for Technical Operations, BioMarin
• Tim Kvanvig, Business Unit Life Sciences, Oracle
SUPPLY CHAIN STRATEGIC SOURCING (SCSS)
STEERING COMMITTEE
Identifying and enabling the sharing of best practices in common
areas of interest relating to strategic sourcing.
CHAIRPERSON: Jim Latimer, Senior Director, Purchasing and
Supply Management, Elan Pharmaceuticals
Committee Members:
• Dan Ambrose, Director Customer Logistics, VWR International
• Paul Anderson, VP, Global Procurement, Life Technologies
• Mark Buck, Global Procurement and Supply Leader, Bio-Rad Laboratories
• Ken Duval, Associate Director, supply chain, shire Pharmaceuticals
•
• Dale Dwier, Manager, strategic sourcing, bayer Healthcare
Rick Fultz, Director, Purchasing Group, biOcOM
• Tom Heebink, business Development & strategic Alliances, biO
• Tim Jordan, Associate Director supply chain, MAP Pharmaceuticals
• Mary Kachinsky, senior Director, strategic sourcing, cubist Pharmaceuticals
• Marc Lampron, senior Director, Procurement, Genentech
• Myles Marcus, Vice President, supply chain, Dendreon
• Mike Mayo, Director, Materials and Procurement, Olympus Biotech
• Mike Mitchell, Director, Supply Chain Management, SAFC Biosciences
• Isaac Young, sr. Dir., supply chain Operations, bioMarin Pharmaceuticals, inc.
• Yingming Yue, Associate Director, Nektar Therapeutics
Pharmaceuticals
paGe
10 /
SUPPLY CHAIN TALENT MANAGEMENT (SCTM)
STEERING COMMITTEE
Developing leaders and programs that increase the capabilities
and skills in the biotech and pharma supply chain community.
CHAIRPERSON: Muffie Dalton, Associate Director, Operations
Planning Genentech
Committee Members:
• Don Wilson, Associate Manager, Amgen
• Keith Launchbury, cfPiM, President, Keith Launchbury and
Associates, Vice chair, bsMA talent Development committee
• Devendra Mishra, founder & executive Director, bio supply
Management Alliance
• Nancy Nix, Ph.D., Executive Director, Executive MBA Program;
Supply Chain Professor, Neeley School of Business, Texas
Christian University
• Dave Malenfant, VP, Global Supply Chain, Alcon Laboratories Inc.
• Phil Kaminsky, Ph.D., Professor, School of Industrial
Engineering, University of California, Berkeley, Site Director,
Center for Excellence in Logistics and Distribution
• Richard Dawe, Ph.D., Professor, Ageno School of Business,
Golden Gate University
• Kevin Pegels, VP, Supply Chain Management, Bayer Healthcare
• Adam Zak, CEO, Adam Zak Executive Search
SUPPLY CHAIN RISK MANAGEMENT (SCRM)
STEERING COMMITTEE
Identifying the best practices for the identification, measurement,
and execution of managing risks in the end-to-end supply chain
of the biotech and pharma industry.
CHAIRPERSON, Vijay Chiruvolu, Director, Operations Risk
Management, Amgen
Committee Members:
• Adam Zak, founder and ceO, Adam Zak executive recruiter
Laboratories
• Arun Cavale, Principal, NexInfo
• Carla Reed, Principal, Tunnell Consulting
• Chris Sam, Executive Director, Craigshannock
• Dave Malenfant, SVP, Global Supply Chain, Alcon
• Jane Lavine, Insurance Executive
• Lew Kontnik, Director of Brand Protection, Amgen
• Michael Mooney, Dir., Risk Management & Insurance - The
Americas, Expeditors
• Mohinder Sikka, CEO, Sensitel
• Ron Bone, SVP, Distribution, McKesson Pharmaceuticals
• Thomas Smith, Director, Supply Chain, Shire Pharmaceuticals
• Yingming Yue, Associate Director, Nektar therapeutics
bio supply ManaGeMent alliance 2014
www.biosupplyalliance.com
STEERING
COMMITTEES
PROMOTING INDUSTRY SUPPLY CHAIN INITIATIVES!
ENVIRONMENTALLY CONTROLLED LOGISTICS
(BIOTECH COLD CHAIN MANAGEMENT)
STEERING COMMITTEE
Identifying the best practices for controlled environmental logistics to maximize patient safety and enhance its value chain.
CHAIRPERSON: Gary Hutchinson, CEO, Modality Solutions
Committee Members:
• Rod Derifield, President, Envicooler
• Don Wilson, Associate Manager, Amgen
• Douglas Wettergren, Regional Sales Manager, Western North
America, Envirotainer
• Ed Church, Executive Director, ISTA
• Jim Cox, CEO, TempTRIP
• Paul Harber, Associate Engineering Consultant, Eli Lilly
MOLECULAR DIAGNOSTICS TESTING STEERING
COMMITTEE
Establish a network and facilitate the sharing and building best
practices, advancing the adoption of information systems and
tools, and meeting the challenges of logistics in emerging
markets of the Molecular Diagnostics Testing segment of the
biopharma industry. The broad areas to be embraced are Sales &
Operations Planning, Materials Management /Strategic Sourcing
and Procurement, Logistics, Information Technologies, Emerging
Markets and SCM in general.
CHAIRPERSON: Mike Crowell, Sr. Director, Supply Chain
Management, Verinata Health
Informing and educating the members about governmental
regulations related to the Biopharma industry and serve as a
resource for the governmental agencies as it develops and
implements regulations.
CHAIRPERSON: Ron Bone, SVP, Distribution, McKesson
Pharmaceuticals
Committee Members:
• Karen Conway, Director, Healthcare, Global Health Exchange
• Lou Kontnik, Director of Brand Protection, Amgen
• Mike Wallace, Director, Global Standards & Serialization,
Enterprise Master Data, Abbott Laboratories
• Wayne McDonnell, Pharma & Life Sciences Advisory,
PricewaterhouseCoopers
SUPPLY CHAIN CLINICAL OPERATIONS (SCCO)
STEERING COMMITTEE
Identifying and enabling the sharing of best practices, knowledge
and experience in clinical supply chain and integrate clinical
operations as a critical segment of the overall supply chain.
CHAIRPERSON: Bill Coakley, Director, SC Planning, Biomarin
Committee Members:
Committee Members:
• Alan Wells, Vice President, Diagnostics Laboratory Operations,
Life Technologies ,
• Andrea Fox, Sales Executive - Life Sciences, FedEx
• Arbi Harootoonian, Vice President, Business Development,
Therapak
• Glen McHenry, Sr. Manager Supply Chain Management,
Monogram Biosciences
• Jordan Myers, Sales Associate, VWR Healthcare
• Karel Hurka Jr, Sr. Manager Supply Chain Management,
Genomic Health
• Scott Krhoun, Supply Chain Operations Manager, Tethys
Biosciences
• Meserve Platt, Associate Director Materials / Facilities, crescendo Bioscience
• Rishi Kacker, Vice President, Engineering, Counsyl Diagnostics
• Susan Jiang, Health Supply Chain Supervisor, Verinata Health
• Tom Schoenherr, Vice President, Business Development,
Counsyl Diagnostics
• Winnie To, Supply Chain Manager, Natera Health
www.biosupplyalliance.com
HEALTHCARE POLICY COMMITTEE
• Philip Chou, Associate Director, Clinical Supplies, Elan
Pharmaceuticals
• Michael Dallmann, Associate Director, Clinical Supplies, Cerexa
• Jaymin Eberhart, Principal, PRTM
• Richard Horn, Associate Director, Supplier Management, Nektar
Therapeutics
• Theodore James Maylath, Manager, Clinical Supply, Abbott
• Amy Penticoff, Associate Director Pharmaceutical Sciences,
NeurogesX, Inc.
bio supply ManaGeMent alliance 2014 / paGe
11